Increased Stretta Production and Enhanced Supply Chain Eases Shipping Backlog

Restech is pleased to announce that we have resolved the supply chain issues involving our Stretta catheter product line which have plagued us over the past eighteen months. Working closely with our manufacturer, Nissha Medical Technologies, we have secured raw material inventories and expanded production capacity which should mitigate the risk of similar supply delays in the future. Commencing immediately, we will begin fulfilling our extensive backlog of orders and will within the next month or two be in a position to fulfill newly placed orders in the normal course of business. Product demand has never been stronger, driven especially by new long-term international contracts in addition to increasing domestic needs.

This has been a challenging period for us at Restech, but we believe we have emerged stronger than ever.  We sincerely appreciate and would like to thank our dedicated partners and staff, distributors, customers, and, most importantly, our patients for sticking with us through this difficult time.  It is a testament to the strength of the Stretta product line in fulfilling the global market’s unmet need for minimally invasive endoscopic antireflux treatments that such a setback has been overcome.

As we fulfill our current backlog of orders and increase production capacity over the next two months, we will gradually reduce lead times from today’s six to eight weeks, to meet our goal of fulfilling the majority of orders in less than ten business days.  As always, we encourage you to reach out with any questions or concerns you may have.

.